NEW ALPHA-2-ADRENERGIC BLOCKER (DG-5128) IMPROVES INSULIN-SECRETION AND INVIVO GLUCOSE DISPOSAL IN NIDDM PATIENTS

被引：45

作者：

KASHIWAGI, A

HARANO, Y

SUZUKI, M

KOJIMA, H

HARADA, M

NISHIO, Y

SHIGETA, Y

机构：

来源：

DIABETES | 1986年 / 35卷 / 10期

关键词：

D O I：

10.2337/diabetes.35.10.1085

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1085 / 1089

页数：5

共 14 条

[1] CIRCULATING C-PEPTIDE IMMUNOREACTIVITY - STUDIES IN NORMALS AND DIABETIC PATIENTS [J].

BLOCK, MB ;

STEINER, DF ;

RUBENSTEIN, AH ;

MAKO, ME .

DIABETES, 1972, 21 (10) :1013-+

[2] TOLBUTAMIDE AND GLYBURIDE DIFFER IN EFFECTIVENESS TO DISPLACE ALPHA-ADRENERGIC AND BETA-ADRENERGIC RADIOLIGANDS IN PANCREATIC-ISLET CELLS AND MEMBRANES [J].

CHERKSEY, B ;

ALTSZULER, N .

DIABETES, 1984, 33 (05) :499-503

[3] ENHANCED GLUCOSE-UTILIZATION DURING PROLONGED GLUCOSE CLAMP STUDIES [J].

DOBERNE, L ;

GREENFIELD, MS ;

SCHULZ, B ;

REAVEN, GM .

DIABETES, 1981, 30 (10) :829-835

[4] IMMUNOASSAY OF INSULIN WITH INSULIN-ANTIBODY PRECIPITATE [J].

HALES, CN ;

RANDLE, PJ .

BIOCHEMICAL JOURNAL, 1963, 88 (01) :137-&

[5] GLUCOSE, INSULIN, AND SOMATOSTATIN INFUSION FOR DETERMINATION OF INSULIN SENSITIVITY INVIVO [J].

HARANO, Y ;

HIDAKA, H ;

TAKATSUKI, K ;

OHGAKU, S ;

HANEDA, M ;

MOTOI, S ;

KAWAGOE, K ;

SHIGETA, Y ;

ABE, H .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1978, 27 (09) :1449-1452

[6]

HARANO Y, 1983, 1ST P INT S TREATMEN, P222

[7]

Hoffman WS, 1937, J BIOL CHEM, V120, P51

[8] INSULIN RELEASING ACTION OF 2-[2-(4,5-DIHYDRO-1H-IMADAZOL-2-YL)-1-PHENYLETHYL] PYRIDINE DIHYDROCHLORIDE SESQUIHYDRATE (DG-5128), A NEW, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT [J].

KAMEDA, K ;

ONO, S ;

KOYAMA, I ;

ABIKO, Y .

ACTA ENDOCRINOLOGICA, 1982, 99 (03) :410-415

[9]

KAMEDA K, 1982, ARZNEIMITTEL-FORSCH, V32-1, P39

[10]

KAMEDA KY, 1981, BIOCHIM BIOPHYS ACTA, V677, P263

← 1 2 →